848580-34-7 Usage
Uses
Used in Pharmaceutical Research and Development:
2,8-Diazaspiro[4.5]decan-1-one, 2-methyl-, hydrochloride (1:1) is used as a building block for the synthesis of biologically active compounds in pharmaceutical research and development. Its unique spiro ring structure contributes to the development of new drugs with potential therapeutic applications.
Used in Antipsychotic and Anxiolytic Agents:
2,8-Diazaspiro[4.5]decan-1-one, 2-methyl-, hydrochloride (1:1) is used as an antipsychotic and anxiolytic agent. It has shown potential in treating mental health disorders, such as schizophrenia and anxiety, by modulating neurotransmitter levels and receptor interactions in the brain.
Used in Neurodegenerative Disease Treatment:
2,8-Diazaspiro[4.5]decan-1-one, 2-methyl-, hydrochloride (1:1) is being investigated for its potential use in the treatment of neurodegenerative diseases. Its unique chemical structure and biological activity may offer new therapeutic approaches for conditions such as Alzheimer's disease, Parkinson's disease, and other related disorders.
Used in Pharmaceutical Formulations:
The hydrochloride salt form of 2,8-Diazaspiro[4.5]decan-1-one, 2-methylis used for its improved solubility and stability in pharmaceutical formulations. This enhances the compound's bioavailability, allowing for more effective drug delivery and therapeutic outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 848580-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,5,8 and 0 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 848580-34:
(8*8)+(7*4)+(6*8)+(5*5)+(4*8)+(3*0)+(2*3)+(1*4)=207
207 % 10 = 7
So 848580-34-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H16N2O.ClH/c1-11-7-4-9(8(11)12)2-5-10-6-3-9;/h10H,2-7H2,1H3;1H
848580-34-7Relevant academic research and scientific papers
DIAZASPIRODECANYL-PYRIMIDINE COMPOUNDS USEFUL AS SSAO INHIBITORS
-
Page/Page column 6, (2018/09/12)
The present invention provides a compound of the Formula (1) below pharmaceutically acceptable salts of the compound of Formula (1), methods of treating patients for liver disease, and processes for preparing the compounds.
